{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:15:35Z","timestamp":1778714135406,"version":"3.51.4"},"reference-count":113,"publisher":"Informa Healthcare","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1517\/14712598.4.1.11","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T15:52:17Z","timestamp":1115221937000},"page":"11-21","source":"Crossref","is-referenced-by-count":10,"title":["T cell-based therapies for EBV-associated malignancies"],"prefix":"10.1517","volume":"4","author":[{"given":"Graham S","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,3,3]]},"reference":[{"key":"CIT0003","first-page":"7374","volume":"68","author":"TIERNEY RJ","year":"1994","journal-title":"J. Vim\/."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.6.2975"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.1234","volume":"71","author":"SHAPIRO RS","year":"1988","journal-title":"Blood"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-2254(199903\/04)1:2<84::AID-JGM21>3.0.CO;2-Q"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.909"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.405"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00912.x"},{"issue":"100","key":"CIT0013","first-page":"1755\u2013","volume":"2002","author":"MOOSMANN A","year":"1764","journal-title":"Blood"},{"key":"CIT0015","first-page":"214","volume":"14","author":"WALKER RC","year":"1995","journal-title":"Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.j Heart Lung Transplant."},{"key":"CIT0016","first-page":"38","volume":"27","author":"HO M","year":"1995","journal-title":"Transplant. Proc."},{"key":"CIT0017","first-page":"2208","volume":"94","author":"CURTIS RE","year":"1999","journal-title":"Blood"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-1-83"},{"key":"CIT0020","first-page":"395","volume":"26","author":"GROSS TG","year":"1998","journal-title":"DAVIS JRet al.: Depletion of EBV-infected cells in donor marrow by counterflow elutriation. Exp. Hematol"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V91.8.3079.3079_3079_3083","volume":"91","author":"HALE G","year":"1998","journal-title":"Blood"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00972.x"},{"key":"CIT0023","first-page":"3654","volume":"91","author":"LUCAS KG","year":"1998","journal-title":"Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood"},{"key":"CIT0025","first-page":"487","volume":"18","author":"VAN LEEUWEN FE","year":"2000","journal-title":"Clin. Omni"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.V93.3.761","volume":"93","author":"AISENBERG AC","year":"1999","journal-title":"Blood"},{"key":"CIT0027","first-page":"339","volume":"177","author":"DEACON EM","year":"1993","journal-title":"G,NIEDOBITEK Get al.: Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. I Exp. Med."},{"key":"CIT0028","first-page":"1664","volume":"1997","author":"NIEDOBITEK G","journal-title":"Blood"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90943-J"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V84.11.3792.bloodjournal84113792","volume":"84","author":"GRASSER FA","year":"1994","journal-title":"Blood"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.V92.7.2477","volume":"92","author":"MURRAY PG","year":"1998","journal-title":"Blood"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V92.3.1020","volume":"92","author":"LEE SP","year":"1998","journal-title":"Blood"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1038\/newbio244245a0"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-5-1051"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420305"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00354-L"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.66.5.2689-2697.1992","volume":"66","author":"BROOKS L","year":"1992","journal-title":"' Virol"},{"key":"CIT0039","first-page":"310","volume":"58","author":"KHANNA R","year":"1998","journal-title":"Cancer Res."},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1038\/194232a0"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60470-4"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1038\/375685a0"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12616"},{"key":"CIT0046","first-page":"791","volume":"7","author":"BLAKE N","year":"1997","journal-title":"kninunio"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088902"},{"key":"CIT0048","first-page":"1537","volume":"9","author":"KHANNA R","year":"1997","journal-title":"Int. Inainunol."},{"key":"CIT0050","first-page":"544","volume":"47","author":"ANDERSSON ML","year":"1991","journal-title":"Aberrant"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250536"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.13.4567"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/6.4.639"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.072495599"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.1.169"},{"key":"CIT0056","first-page":"157","volume":"176","author":"MURRAY RJ","year":"1992","journal-title":"MG,BROOKS JM et al.: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. I Exp. Med."},{"key":"CIT0057","first-page":"3325","volume":"158","author":"LEE SP","year":"1997","journal-title":"I kninunol"},{"key":"CIT0058","first-page":"451","volume":"28","author":"KHANNA R","year":"1998","journal-title":"Eur: hannunol"},{"key":"CIT0059","first-page":"1827","volume":"162","author":"TAN LC","year":"1999","journal-title":"kninunol"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10309"},{"issue":"7078","key":"CIT0061","volume":"165","author":"BLAKE N","year":"2000","journal-title":"SHAKMA G, CROOM-CARTER D, RICKINSON A: The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNAL j kninunol"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1126\/science.1082305"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083317"},{"key":"CIT0067","first-page":"8649","volume":"75","author":"LEEN A","year":"2001","journal-title":"J. Vim\/."},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)01896-8"},{"issue":"2","key":"CIT0072","first-page":"217","volume":"77","author":"POLIC B","year":"1996","journal-title":"Virol."},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.8.3740-3752.2001"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.0076"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1996.tb00703.x"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.46.29127"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.9.1513"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2632"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200323730"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301703"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409083311017"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91150-2"},{"key":"CIT0086","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","volume":"92","author":"ROONEY CM","year":"1998","journal-title":"Blood"},{"key":"CIT0087","first-page":"98","volume":"89","author":"ROONEY CM","year":"1995","journal-title":"Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br.! Haematol."},{"key":"CIT0088","first-page":"807","volume":"95","author":"GUSTAFSSON A","year":"2000","journal-title":"ZOU JZet al.: Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood"},{"key":"CIT0089","first-page":"583","volume":"1","author":"STARZL TE","year":"1984","journal-title":"MA,PORTER KA et al.: Reversibility of lymphomas and lymphoproliferative lesionsdeveloping under cyclosporin-steroid therapy. Lancet"},{"key":"CIT0090","first-page":"6204","volume":"160","author":"HAQUE T","year":"1998","journal-title":"Immunol."},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1089\/scd.1.1998.7.257"},{"key":"CIT0092","first-page":"455","volume":"20","author":"O'REILLY RJ","year":"1998","journal-title":"Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer &min. Immunopathol."},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.18.10391"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000058745.02123.6F"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200011270-00019"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2.1.97"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03041.x"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2644"},{"key":"CIT0101","first-page":"100","volume":"73","author":"VERSCHUUREN EA","year":"2002","journal-title":"VAN IMHOFF GW et al.: Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation"},{"key":"CIT0103","first-page":"5782","volume":"159","author":"KHANNA R","year":"1997","journal-title":"J. Inununol."},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<772::AID-IJC13>3.0.CO;2-G"},{"key":"CIT0105","first-page":"4298","volume":"77","author":"ONG KW","year":"2003","journal-title":"\" Vim]."},{"key":"CIT0106","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V89.6.1978","volume":"89","author":"SING AP","year":"1997","journal-title":"Blood"},{"key":"CIT0107","first-page":"6219","volume":"61","author":"CHAPMAN AL","year":"2001","journal-title":"Cancer Res."},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910180202"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91379-9"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910320307"},{"key":"CIT0111","first-page":"673","volume":"17","author":"SLIVNICK DJ","year":"1990","journal-title":"Semin. Oncol"},{"key":"CIT0112","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","volume":"91","author":"ROSKROW MA","year":"1998","journal-title":"Blood"},{"key":"CIT0113","first-page":"73","volume":"94","author":"CHUA D","year":"2001","journal-title":"hat. J. Cancer"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1038\/32588"},{"key":"CIT0115","first-page":"334","volume":"73","author":"RED CHENKO IV","year":"1999","journal-title":"J. Vim]."},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200103)31:3<947::AID-IMMU947>3.0.CO;2-M"},{"key":"CIT0117","first-page":"1905","volume":"2003","author":"GOTTSCHALK S","journal-title":"Blood"},{"key":"CIT0118","first-page":"10416","volume":"73","author":"RANIERI E","year":"1999","journal-title":"J. Vim]."},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1396"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3092"},{"key":"CIT0121","first-page":"6952","volume":"62","author":"LIN CL","year":"2002","journal-title":"Cancer Res"},{"key":"CIT0124","first-page":"253","volume":"107","author":"MAHNEL H","year":"1994","journal-title":"Berl. Munch. Tierarzil Wochenschr."},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1038\/nm881"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.1038\/nm0498-397"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390190075023"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1086\/314585"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00315-8"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10094"},{"key":"CIT0133","first-page":"730","volume":"43","author":"THORLEY-LAWSON DA","year":"1982","journal-title":"Vim\/"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1038\/318287a0"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-8-2093"},{"key":"CIT0137","first-page":"171","volume":"84","author":"GU SY","year":"1995","journal-title":"Dev. Biol. Stand"},{"key":"CIT0139","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2030"},{"key":"CIT0140","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60864-7"},{"key":"CIT0141","first-page":"421","volume":"35","author":"TSAI ST","year":"1999","journal-title":"Oral \u00b0flea"},{"key":"CIT0142","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0099"},{"key":"CIT0143","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.663"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.4.1.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T06:28:30Z","timestamp":1586240910000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.4.1.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,3,3]]},"published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1517\/14712598.4.1.11"],"URL":"https:\/\/doi.org\/10.1517\/14712598.4.1.11","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}